BioSpace News Archive

Lone Star Bio

Bellicum Pharmaceuticals to Participate in the 2022 Cell & Gene Meeting on the Mesa

Bellicum Pharmaceuticals, Inc. today announced that Rick Fair, President and CEO, will present at the annual Cell & Gene Meeting on the Mesa to be held October 11-13 in Carlsbad, CA and livestreamed globally.

October 4, 2022
·
1 min read
Blue-Zone Technologies, Ltd. Secures $8 Million of Institutional Financing

Blue-Zone Technologies, Ltd. resulting in the production of branded generic anesthetics, is proud to announce an $8 million round of institutional financing jointly led by the Canadian Venture Capital arm of Crédit Mutuel Equity and Round Pound Ventures, LLC.

October 4, 2022
·
5 min read
Drug Development

MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA

Mind Medicine today announced the initiation of a Phase 1 investigator-initiated trial led by MindMed collaborator Prof. Dr. Matthias Liechti at University Hospital Basel (UHB).

October 4, 2022
·
5 min read
Lone Star Bio

Gradalis to Present at the 2022 Cell & Gene Meeting on the Mesa

Gradalis, Inc. announced that Steven Engle, Chief Executive Officer, will provide a corporate update at the 2022 Cell & Gene Meeting on the Mesa being held both virtually and in Carlsbad, California on October 11 – 13, 2022.

October 4, 2022
·
4 min read
Drug Development

Abcuro Initiates Phase 1/2 Trial Evaluating ABC008 in Patients with T Cell Large Granular Lymphocytic Leukemia

Abcuro, Inc. announced initiation of a Phase 1/2 dose escalation trial to evaluate the safety, tolerability, and proof-of-concept of ABC008 in patients with T cell large granular lymphocytic leukemia who suffer from anemia and/or neutropenia.

October 4, 2022
·
2 min read